Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Lalloo

Showing results (41-50 of 162) with videos related to

Pageof 17
Sort By:
JAMA Oncology|August 4, 2017
Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance StrategiesNeil A J Ryan, Julie Morris, Kate Green, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2009
Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependentD Gareth R Evans, Fiona Lalloo, Linda Ashcroft, et al.
European Journal of Human Genetics : EJHG|December 6, 2021
30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genesEmma R Woodward, Kate Green, George J Burghel, et al.
Breast Cancer Research and Treatment|November 20, 2013
Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referralSarah L Ingham, Matthew Sperrin, Andrew Baildam, et al.
Journal of Medical Genetics|June 30, 2025
Evaluation of whole-body MRI for cancer early detection in Li-Fraumeni syndromePeter Sodde, Zerin Hyder, Sarah Pugh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Impaired tamoxifen metabolism reduces survival in familial breast cancer patientsWilliam G Newman, Kristen D Hadfield, Ayshe Latif, et al.
Journal of Medical Genetics|May 12, 2017
Pathology update to the Manchester Scoring System based on testing in over 4000 familiesD Gareth Evans, Elaine F Harkness, Inga Plaskocinska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2026
Survival Outcomes With or Without Risk-Reducing Mastectomy in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variant CarriersAshu Gandhi, Sacha J Howell, Elaine F Harkness, et al.
Journal of Medical Genetics|July 25, 2024
Germline testing for breast cancer patients in England: illogical to prioritise grade 1 breast cancer aged 30-39 over grade 3 aged 40-49 years?D Gareth Evans, Sacha J Howell, George J Burghel, et al.
Plastic and Reconstructive Surgery|June 24, 2022
Surgical Outcome Measures in a Cohort of Patients at High Risk of Breast Cancer Treated by Bilateral Risk-Reducing Mastectomy and Breast ReconstructionAshu Gandhi, Paula Duxbury, Tara Clancy, et al.
Pageof 17

Showing results (41-50 of 162) with videos related to

Sort By:
Pageof 17
JAMA Oncology|August 4, 2017
Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance StrategiesNeil A J Ryan, Julie Morris, Kate Green, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2009
Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependentD Gareth R Evans, Fiona Lalloo, Linda Ashcroft, et al.
European Journal of Human Genetics : EJHG|December 6, 2021
30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genesEmma R Woodward, Kate Green, George J Burghel, et al.
Breast Cancer Research and Treatment|November 20, 2013
Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referralSarah L Ingham, Matthew Sperrin, Andrew Baildam, et al.
Journal of Medical Genetics|June 30, 2025
Evaluation of whole-body MRI for cancer early detection in Li-Fraumeni syndromePeter Sodde, Zerin Hyder, Sarah Pugh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Impaired tamoxifen metabolism reduces survival in familial breast cancer patientsWilliam G Newman, Kristen D Hadfield, Ayshe Latif, et al.
Journal of Medical Genetics|May 12, 2017
Pathology update to the Manchester Scoring System based on testing in over 4000 familiesD Gareth Evans, Elaine F Harkness, Inga Plaskocinska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2026
Survival Outcomes With or Without Risk-Reducing Mastectomy in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variant CarriersAshu Gandhi, Sacha J Howell, Elaine F Harkness, et al.
Journal of Medical Genetics|July 25, 2024
Germline testing for breast cancer patients in England: illogical to prioritise grade 1 breast cancer aged 30-39 over grade 3 aged 40-49 years?D Gareth Evans, Sacha J Howell, George J Burghel, et al.
Plastic and Reconstructive Surgery|June 24, 2022
Surgical Outcome Measures in a Cohort of Patients at High Risk of Breast Cancer Treated by Bilateral Risk-Reducing Mastectomy and Breast ReconstructionAshu Gandhi, Paula Duxbury, Tara Clancy, et al.
Pageof 17